跳到主要內容

MIT Fires Professor Van Parijs for Using Fake Data in Papers

http://www-tech.mit.edu/V125/N50/50van_parijs.html

MIT Fires Professor Van Parijs for Using Fake Data in Papers

--------------------------------------------------------------------------------
CORRECTION TO THIS ARTICLE: An Oct. 28 front-page article about MIT’s dismissal of Professor Luk Van Parijs incorrectly described one of his former research collaborators. While Michael McManus has been a coauthor with Van Parijs on several papers, he did not work in Van Parijs’ laboratory.
--------------------------------------------------------------------------------

By Kelley Rivoire
EDITOR IN CHIEF

Professor of Biology Luk Van Parijs has been dismissed after admitting to fabricating and falsifying research data, MIT announced yesterday.

Van Parijs, who came to MIT five years ago and was promoted to associate professor last July, first came under fire in August 2004, when members of his laboratory in the Center for Cancer Research reported allegations of misconduct to MIT. They “couldn’t find or identify some of the data,” said Alice P. Gast, vice president for research and associate provost. Van Parijs could not be reached for comment yesterday.

The subsequent investigation launched by MIT, which Gast oversaw, concluded this week and made recommendations to Provost L. Rafael Reif, who made the decision to dismiss Van Parijs, she said. The investigation, conducted by “senior members of the community,” whom Gast declined to name specifically, only concerned Van Parijs’ work at MIT, she said.

There was a “serious enough set of allegations and admission by him that he was put on leave and denied access to his lab” immediately last August, Gast said.

None of his coauthors have been implicated, Gast said, and retractions will be printed on the appropriate articles. “We’ll be helping the coauthors to ensure that they’re all participants in retractions,” but “it’s the coauthors’ responsibility,” she said.

Gast declined to comment on which papers would be retracted or what specific body of work was affected. Van Parijs, whose research focuses on immune system functions and RNAi technologies, has published about 20 research papers since arriving at MIT, including a 2003 paper in Nature Genetics that has been cited 247 times. A paper in Science in which he was lead author, published in 1998 before he came to MIT, has drawn 461 citations. Van Parijs obtained his doctoral degree from Harvard in 1997.

Van Parijs’ coauthors in research papers include Professors Tyler E. Jacks, Rudolf Jaenisch, Harvey F. Lodish, Frank Gertler, Institute Professor and Nobel Laurate Phillip A. Sharp, and Nobel Laureate and Caltech President David Baltimore. Baltimore, who declined to comment, was previously involved in a lengthy investigation into alleged misconduct by a coauthor, who was eventually exonerated. Several of Van Parijs’ other coauthors also declined to comment.

MIT’s current scientific misconduct policy has been in place for over a decade, Gast said, and during that time there have been no incidents.

Gast praised the members of Van Parijs’ research group who brought forward the allegations of misconduct. “It’s really those closest to the research that would be able to determine or notice something like this. It’s a case where the system worked, and they felt comfortable coming forward.” The “process worked exactly the way you would want it to,” she said.

The “investigation is a confidential process to fully gather all the facts related to the case,” she said. “It involves collecting information from materials as well as interviews with the people bringing forward the allegations as well as the respondent … as well as others involved in the research. It’s a confidential process, and it was done very carefully and very thoroughly over the 14-month period.”

Van Parijs admitted to fabricating and falsifying research data in a paper and several manuscripts and grant applications over the course of the investigation, according to an MIT press release.

Because part of Van Parijs’ funding came from the federal government, the U.S. Office of Research Integrity will also conduct a confidential investigation, Gast said. The Office of Research Integrity in the Department of Health and Human Services was created in 1989 to investigate scientific fraud.

While the physics community was rocked in 2002 by the revelation that Bell Labs star physicist Jan Hendrik Schön had falsified data on which many others had subsequently based their research, it seems unlikely that this incident will have the same effects.

“The field is quite a vibrant field with many excellent people doing outstanding work,” Gast said. She said she did not think it would significantly impact the field of RNAi research.

Peter Sandy, a postdoctoral associate who spent a year working with Van Parijs, also doubted the broader impact of Van Parijs’ actions. “I don’t think that it will affect the field because there are a lot of great publications,” he said, and “most of the things they published I think are true.”

Regarding his own work, he said his research will be unaffected, as he no longer works on the same projects as he did while in Van Parijs’ laboratory.

Michael McManus, a University of California San Francisco professor who formerly worked in Van Parijs’ laboratory, also said that the incident “doesn’t really affect my work.”

Gast said that Van Parijs’ former graduate students “have been able to carry on their research with new advisors and new projects.” MIT has “done the best we can to take care of their futures,” she said.

In recent years, many have called into question the competitive “publish-or-perish” environment that can drive scientific research. Nicholas Steneck, University of Michigan professor of history and a consultant for the ORI, reported in 2000 that while one in 100,000 researchers had been involved in misconduct cases, reported knowledge of misconduct is higher than one percent.

Gast said she said that she knew of no similar conduct by other individuals or environment that would lead to such conduct at MIT. “It’s an isolated individual behavior,” she said. “I don’t think it’s endemic or systemic.” Nonetheless, the case “may serve as an important lesson” that “integrity is extremely important to scientific research,” she said.

Beckett W. Sterner contributed to the reporting of this story.



留言

這個網誌中的熱門文章

台灣桌球運動的未來在哪?

之前看到客家新聞雜誌針對新埔桌訓做的報導:台灣乒未來 裡面很清楚地介紹了新埔桌訓,以及點出不少台灣桌球界的問題 甚至,我覺得這些其實是台灣運動界的共有問題 請先看這兩段影片吧 (如果只想看裡面提到的問題,請直接看第2段; 但我強力建議從第一個影片開始看,因為可以看到葉教練用心帶球隊,還有球員們很認真用心練球的過程)

FW: 以毒攻毒、種痘不得痘──人類戰痘的免疫史 (中)

【文/江漢聲(作者為輔仁大學醫學院院長)】 如果要說「以毒攻毒」,那麼同樣在十八世紀出現的「順勢療法」(Homeopathy)才是最激烈的一種另類療法。德國的哈內曼(C. FS. Hahnemann)觀察金雞納樹皮發熱,用來治療瘧疾的熱很有效,於是他提出以症狀相似的狀況來治療症狀,像辣椒治療發燒、鴉片治療昏睡症;他說引起疾病的原因就是治療疾病的根本,所以他反對「對抗性」的治療,像以鎮靜劑來治療亢奮,或抗菌劑來殺菌,他的用藥原則是以少量的藥物來加強生命力,使生命力元氣增加,就可以消除症狀。這些藥物如果大量或過量中毒就是病人的病因,所以他把任何酊劑都稀釋成為無害的藥物做各種病的治療。這種療法馬上在歐美廣為流行,甚至有「同源療法」(isopathotherapy)的學派產生,主張直接用疾病的病源來治病,像以淋病膿汁治淋病,口服寄生蟲來治寄生蟲,如此「以毒攻毒」的作法也太荒謬了一些。 中國人最早迎戰天花 其實那時候最毒的傳染病是天花,「以毒攻毒」的理論似乎就是免疫學的靈感,但並沒有人想到用在天花。十八世紀時,天花在歐洲已散佈了至少兩百年,沒人知道它從什麼地方來,只知道它愈來愈普遍,在所有傳染病中,像天花這種容易感染給小孩的最為凶猛,有20%到40%的死亡率。在1719年一次流行中,巴黎就死了1萬4千人,1770年印度死亡人數超過300萬,全歐洲沒有一個國家不受其蹂躪,據估計,十八世紀共奪走歐洲6000萬人的性命。這種病毒感染,會使一個人突然高燒、頭痛、背痛、嘔吐和譫妄,進入緊急狀況,到三、四天後,皮膚出現紅色斑點,幾天後轉變成膿泡。這些膿泡多半出現在臉部眼睛,也會出現在前臂、四肢,如果病人存活下來,幾個星期後膿泡會結痂脫落,但就留下永遠無法消除的疤痕,稱之為天花。在十七、十八世紀間,全倫敦有三分之一的人口帶著天花,而三分之二的盲人是由於天花所引起的。 在東方的中國,似乎更早受到天花的毒害。在古籍《皇帝內經》中並無記載,所以相傳是漢代馬援西征所帶回來的傳染病,在東晉開始流行,稱之為「虜瘡」,隋唐時則稱為「豌豆瘡」。巢元方《諸病源候論》已有詳細敘述,〈時氣皰瘡候〉中認為這種全身都是的皰瘡,行如登豆,又稱「登豆瘡」,外形紫黑,則毒氣重;到了宋朝才稱為豆瘡,後來改「豆」為「痘」;明朝時天花已經常流行而成為一種常見的疾病。 相當於西方十七世紀的中國明朝末年,中國天花流行的情況據說有